Increased Serum Mir-150-3p Expression Is Associated with Radiological Lung Injury Improvement in Patients with COVID-19

Autor(es):Mostrar menos -

Bueno, Larissa C. M. ; Paim, Layde R. ; Minin, Eduarda O. Z. ; da Silva, Luis Miguel ; Mendes, Paulo R. ; Kiyota, Tatiana A. ; Schreiber, Angelica Z. ; Bombassaro, Bruna ; Mansour, Eli ; Moretti, Maria Luiza ; Chow, Jonathan Tak-Sum ; Salmena, Leonardo ; Coelho-Filho, Otavio R. ; Velloso, Licio A. ; Nadruz, Wilson ; Schreiber, Roberto

• Tipo de documento: Artigo Científico
• Fonte: Viruses-Basel; v. 14, n. 7, p. 11-pg., 2022-07-01.

Resumo

Coronavirus disease 2019 (COVID-19) is caused by the SARS-CoV-2 virus, responsible for an atypical pneumonia that can progress to acute lung injury. MicroRNAs are small non-coding RNAs that control specific genes and pathways. This study evaluated the association between circulating miRNAs and lung injury associated with COVID-19. Methods: We evaluated lung injury by computed tomography at hospital admission and discharge and the serum expression of 754 miRNAs using the TaqMan OpenArray after hospital discharge in 27 patients with COVID-19. In addition, miR-150-3p was validated by qRT-PCR on serum samples collected at admission and after hospital discharge. Results: OpenArray analysis revealed that seven miRNAs were differentially expressed between groups of patients without radiological lung improvement compared to those with lung improvement at hospital discharge, with three miRNAs being upregulated (miR-548c-3p, miR-212-3p, and miR-548a-3p) and four downregulated (miR-191-5p, miR-151a-3p, miR-92a-3p, and miR-150-3p). Bioinformatics analysis revealed that five of these miRNAs had binding sites in the SARS-CoV-2 genome. Validation of miR-150-3p by qRT-PCR confirmed the OpenArray results. Conclusions: The present study shows the potential association between the serum expression of seven miRNAs and lung injury in patients with COVID-19. Furthermore, increased expression of miR-150 was associated with pulmonary improvement at hospital discharge. (AU)

• Processo FAPESP: 17/23563-1 - Expressão de microRNAs e sua relação com hipertrofia cardíaca em pacientes hipertensos
• Beneficiário: Roberto Schreiber
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 13/07607-8 - CMPO - Centro Multidisciplinar de Pesquisa em Obesidade e Doenças Associadas
• Beneficiário: Licio Augusto Velloso
• Modalidade de apoio: Auxílio à Pesquisa - Centros de Pesquisa, Inovação e Difusão - CEPIDs